Global Phylloquinone Market is Likely to Grow a CAGR of 7.95% during the Forecast Period

The latest market report published by Credence Research, Inc. “Global Phylloquinone Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”. The Global Phylloquinone Market generated revenue of around USD 483.92 million in 2021 and is anticipated to grow a CAGR of over 7.95% during the forecast period from 2022 to 2028 to reach around USD 880.66 million in 2028. While, cumulative growth opportunity presented by the global Phylloquinone is around USD 4.96 billion during 2022 to 2028.

Global Phylloquinone Market, 2021 – 2028 (USD Million)

Browse the full report at  Phylloquinone Market Size, Trends, Share and Growth Report Forecast to 2028 | Credence Research

Phylloquinone is also widely known as Vitamin K or Phytomenadione is generally found in food and usually taken as a dietary supplement. Phylloquinone is quite effective in treatment of some disorders which includes vitamin k deficiency, obstructive jaundice and warfarin overdose. Phylloquinone is generally taken as oral supplement or sometime may be parental and topical. However, consumption of Phylloquinone is associated with certain side effects such as pain at the site of injection and alteration of taste. Exceptionally it may cause severe allergic reaction.

Pharmaceutical Grade Phylloquinone to Held the Largest Share

Food Grade and Pharmaceutical Grade are some of the important grades of Phylloquinone. Pharmaceutical Grade Phylloquinone is most widely used grade of Phylloquinone used across various applications. It accounted for over 75% share in total revenue generation in 2021. While, Food Grade Phylloquinone also hold the significant share and likely to exhibit attractive CAGR over the span of analysis period.

Oral Route of Administration to Grow at Rapid Pace

Parental, Oral and Topical are major Route of Administration segments of the global Phylloquinone industry. Oral Route of Administration is fastest growing segments for Phylloquinone. While, topical and parental segment held over 30% share in 2021. Oral Route of Administration is highly popular as its possess least side effects.

Vitamin K Deficiency to Rule the Demand for Phylloquinone

Vitamin K deficiency, Warfarin overdose, Obstructive jaundice, Osteoporosis and Others are major application markets of Phylloquinone. Vitamin K deficiency is largest application industries for Phylloquinone with over 45% share in 2021. While, Osteoporosis application is likely to advance at a rapid pace over the forecast period.

U.S. is Leading Phylloquinone Demand in Asia Pacific

U.S. is leading the Phylloquinone industry in North America with over 80% share in 2021. While, India, Japan and South Korea are likely to advance at a rapid pace over the forecast period in Asia Pacific. On the other hand UK, Germany and France are dominating European market and expected to post attractive CAGR during the forecast period. However, U.S. is single largest market for Phylloquinone in world with over 305% share in 2021.

Major players operating in the global Phylloquinone  market include Shandong Guangtongbao Pharmaceuticals, Anhui Wanhe Pharmaceutical, Nutrilo, DSM, Yongan Pharmceutical, Zhejiang Chengyi Pharmaceutical and BASF SE. Global Phylloquinone market is characterized by the presence of large number of manufacturers across the world.

Market Segmentation

Global Phylloquinone Market by Grade, 2016 – 2028

  • Food Grade
  • Pharmaceutical Grade

Global Phylloquinone Market by Route of Administration, 2016 – 2028

  • Parental
  • Oral
  • Topical

Global Phylloquinone Market by Application, 2016 – 2028

  • Vitamin K deficiency
  • Warfarin overdose
  • Obstructive jaundice
  • Osteoporosis
  • Others

Global Phylloquinone Market by Company, 2016 – 2028

  • Shandong Guangtongbao Pharmaceuticals
  • Anhui Wanhe Pharmaceutical
  • Nutrilo
  • DSM
  • Yongan Pharmceutical
  • Zhejiang Chengyi Pharmaceutical
  • Others